Brief: PolarityTE Provides Update On U.S. FDA Investigational New Drug Application For SkinTE

RegenETP,

24/08/2021 13:34

Aug 24 (Reuters) - PolarityTE Inc  PTE.O :
    * POLARITYTE PROVIDES UPDATE ON U.S. FDA INVESTIGATIONAL NEW
DRUG
APPLICATION FOR SKINTE®
    * POLARITYTE INC - STUDY PROPOSED IN IND HAS BEEN PLACED ON
CLINICAL HOLD
    * POLARITYTE INC - FDA HAS ADVISED THAT IT WILL ISSUE A
CLINICAL
HOLD LETTER PROVIDING DETAILS ON BASIS FOR HOLD TO COMPANY BY
SEPTEMBER 21, 2021

Source text for Eikon:  ID:nBw8dCLYsa 
Further company coverage:  PTE.O 

 (((Reuters.Briefs@thomsonreuters.com);))